ANCHOR Diagnostics has entered into a strategic distribution partnership with XboXLab, strengthening support for molecular diagnostics in the Nordic region, specifically including Sweden, Norway, and Finland.
Debunking Misconceptions in Molecular Diagnostics | ANCHOR Diagnostics
PCR (Polymerase Chain Reaction) testing has long become a cornerstone of modern infectious disease diagnostics. However, in today’s fast-paced healthcare environment, a number of persistent myths continue to shape lab decisions sometimes with unintended consequences. At ANCHOR Diagnostics, we believe clarity is key to clinical confidence. So, in this edition of our Myth vs Fact series, we’re tackling five common misconceptions about PCR diagnostics - and setting the record straight.
Proven Workflow Flexibility for CMV Detection in Routine Diagnostics
In today’s molecular diagnostics landscape, laboratories need more than sensitivity, they need solutions that fit seamlessly into their existing workflows.
At ANCHOR Diagnostics, innovation is the driving force behind everything we do. As we continue to expand and push the boundaries of molecular diagnostics with high-speed PCR solutions, we recognized the need for a brand identity that reflects our commitment to superior quality, precision, reliability "Made in Germany", and our future-oriented strategy. That’s why we are excited to introduce our refreshed logo and brand-new website – designed to enhance clarity and solidify our professional representation across all platforms.
A Modern, Minimalist Design
ANCHOR Diagnostics is pleased to announce a new partnership with Max Care, a leading distributor of medical devices and equipment in Saudi Arabia.
Streamlining Laboratory Workflow with Multiplex Molecular Diagnostics
ANCHOR Diagnostics is expanding its 30-minute PCR portfolio with the launch of the ANCHOR HHV-6/7/8 Multiplex PCR Kit, an advanced molecular assay designed for the rapid detection and quantitation of Human Herpesviruses 6, 7, and 8 (HHV-6, HHV-7, HHV-8). These viruses are associated with opportunistic infections and can lead to severe clinical symptoms in immunocompromised patients, such as transplant recipients and individuals with weakened immune systems.
At ANCHOR Diagnostics, research and innovation are central to how we work. We are proud to share that our efforts have been recognized with the BSFZ Seal for Research and Development from the German Federal Ministry of Education and Research. This seal is awarded after a formal review process and demonstrates that our projects fulfill strict criteria for novelty, scientific value, and measurable technological progress.
The global diagnostics industry continues to evolve, and platforms like Medlab Middle East 2025 serve as vital convergence points for professionals, innovators, and thought leaders. This year, ANCHOR Diagnostics had the opportunity to exhibit at the event, marking a significant step forward in our journey to bring advanced molecular diagnostic solutions to the world.
We’re proud to announce an exclusive distribution partnership with Stratech Ltd, a leading provider of life science reagents and diagnostic tools over 40 years of experience in the UK and Ireland.
In response to the growing global demand for fast, accurate, and efficient diagnostic tools during a season marked by increasing respiratory infections, ANCHOR Diagnostics launched ANCHOR Viral Respiratory Multiplex PCR Kit (RUO) on 27 November 2024. This cutting-edge diagnostic solution is specifically designed to help laboratories detect and differentiate between some of the most common and concerning respiratory viruses in just 30 minutes: SARS-CoV-2, Influenza A, Influenza B, and RSV (Respiratory Syncytial Virus).